Atypical Oncologic Failure After Laparoscopic Radical Nephroureterectomy in a Japanese Multicenter Study

J Endourol. 2023 Jul;37(7):793-800. doi: 10.1089/end.2023.0072. Epub 2023 Jun 14.

Abstract

Objectives: To investigate the recurrence patterns and the atypical oncologic failure (AOF) defined as the presence of atypical recurrences, such as retroperitoneal carcinomatosis or port-site recurrence, after laparoscopic radical nephroureterectomy (LRNU). Methods: LRNU performed at three institutions were included in this retrospective study. The primary endpoints were the first recurrence site and recurrence-free survival. The recurrence sites were classified as atypical recurrences, such as retroperitoneal carcinomatosis or port-site recurrence, as well as distant, local, and intravesical. The Kaplan-Meier curves were obtained to elucidate the time until recurrence and survival. Results: A total of 283 patients were included in the final analysis. Postoperative pathology was T3 or higher in 112 (40%) patients. The median follow-up period was 31 months, and the 3-year recurrence-free, cancer-specific, and overall survival rates were 69.6%, 78.1%, and 72.0%, respectively. The first recurrence sites involved distant, local, atypical, and intravesical recurrences in 51 (18%), 36 (13%), 14 (5%), and 94 (33%) patients, respectively. Of the 14 patients with AOF, 12 had pathologically locally advanced tumors, but seven patients had a preoperative diagnosis of clinical stage T2 or less. Conclusion: A small number of AOF cases were found after LRNU for patients with upper tract urothelial carcinoma. Careful patient selection is critical for AOF prevention.

Keywords: atypical oncologic failure; laparoscopic radical nephroureterectomy; upper tract urothelial carcinoma.

Publication types

  • Multicenter Study

MeSH terms

  • Carcinoma, Transitional Cell* / surgery
  • East Asian People
  • Humans
  • Laparoscopy* / adverse effects
  • Neoplasm Recurrence, Local / surgery
  • Nephroureterectomy
  • Retrospective Studies
  • Ureteral Neoplasms* / surgery
  • Urinary Bladder Neoplasms* / surgery